Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2008

View Archived Issues

Amgen presents results from a phase II study of AMG-108 in RA patients

Trial data show beneficial effects of epratuzumab in systemic lupus erythematosus

Atrasentan-liposomal doxorubicin combination feasible in platinum-resistant ovarian cancer

Nanocort safe in rheumatoid arthritis patients

ITF-2357 affects disease activity in systemic onset juvenile idiopathic arthritis

Esreboxetine improves pain, function and fatigue in double-blind fibromyalgia study

Athersys achieves development milestone in Bristol-Myers discovery alliance

Duska and DSM enter manufacturing collaboration for ATPace

Medtronic acquires CryoCath Technologies

Clinical data on CP-690550 in rheumatoid arthritis accumulates

AMG-623 characterized in phase I studies in systemic lupus erythematosus patients

FDA accepts TheraQuest's IND for abuse deterrent opioid TQ-1015

Novel compounds for lipoprotein disorders described in recent patents

Genetic Immunity doses first patient in phase II DermaVir Patch trial for HIV

Sygnis receives European orphan drug status for AX-200 in spinal cord injury

New antidiabetic agents disclosed in recent patent literature

GSK and Janssen patents divulge new therapeutics for GI disorders

Recent patent literature reports new oncolytic agents

Daiichi Sankyo commences phase III anti-influenza CS-8958 trial

FDA approves Banzel as adjunctive treatment for Lennox-Gastaut syndrome

Vernalis presents an update on clinical activities between July and November 2008

Third quarter highlights at AEterna Zentaris

Pfizer launches independent research unit Pfizer Regenerative Medicine

New glycine transporter GlyT1 inhibitor profiled at Merck & Co.

Merck Eprova imparts new PET imaging agents in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...